1,329
Participants
Start Date
March 31, 2006
Primary Completion Date
April 30, 2008
Study Completion Date
June 30, 2010
Gefitinib
oral tablet
Carboplatin
IV
Paclitaxel
IV
Research Site, Fuzhou
Research Site, Guangzhou
Research Site, Wuhan
Research Site, Nanjing
Research Site, Dalian
Research Site, Chongqing
Research Site, Beijing
Research Site, Chengdu
Research Site, Hangzhou
Research Site, Shanghai
Research Site, Hong Kong
Research Site, Semarang
Research Site, Malang
Research Site, Jakarta
Research Site, Solo
Research Site, Surabaya
Research Site, Yogyakarta
Research Site, Nagoya
Research Site, Okazaki
Research Site, Kashiwa
Research Site, Matsuyama
Research Site, Fukuoka
Research Site, Sapporo
Research Site, Akashi
Research Site, Kobe
Research Site, Kanazawa
Research Site, Yokohama
Research Site, Kumamoto
Research Site, Ōmura
Research Site, Okayama
Research Site, Izumisano
Research Site, Osaka
Research Site, Sakai
Research Site, Sayama
Research Site, Sunto-gun
Research Site, Bunkyo-ku
Research Site, Koto-ku
Research Site, Shinjuku
Research Site, Ube
Research Site, Kota Kinabalu
Research Site, George Town
Research Site, Kampung Baharu Nilai
Research Site, Kuala Lumpur
Research Site, Petaling Jaya
Research Site, Cebu City
Research Site, Manila
Research Site, Quezon City
Research Site, Singapore
Research Site, Changhua
Research Site, Kaohsiung City
Research Site, Taipei
Research Site, Taoyuan District
Research Site, Bangkok
Research Site, Chiang Mai
Research Site, Khon Kaen
Research Site, Songkhla
Lead Sponsor
AstraZeneca
INDUSTRY